«This is potentially
the new Human Genome Project,» Karr said.
When Boeke met with Sc2.0 colleagues last summer to discuss their next target organism, San Francisco, California — based futurist Andrew Hessel of the software company Autodesk «sort of made this impassioned speech» for
a new human genome project that would capture the public's imagination and inspire the field around a single goal, Boeke says.
But when she got an offer to start her own research group studying the evolutionary history of Latin Americans at Mexico's
new human genome research institute, less than 3 years after finishing her Ph.D., she couldn't turn it down.
Not exact matches
J. Craig Venter, the superstar geneticist who mapped the first
human genome in 2000, has a
new challenge: decoding death.
Craig Venter, a biologist and entrepreneur as well as one of the first people to map the
human genome, wants to make 100 the
new 60.
Research on a
new «gene editing» technology known as CRISPR — which theoretically allows any cell or organism to have its
genome altered — is advancing exponentially, with early research ongoing on
human embryos created for that purpose.
The principles that have emerged thus far are these: We should seek
new knowledge of our genes (and we can say this without deciding whether the
Human Genome Initiative is the wisest and most cost - effective way to do so) We should seek therapies for the genetic disorders that afflict many people.
He notes that the
Human Genome Initiative will increase the capacity to screen out undesirable traits «by identifying
new genes for carrier and prenatal testing, including, potentially, genes for alcoholism, homosexuality and depression.»
In a research paper published in April last year, Chinese scientists described how they were able to manipulate the
genomes of
human embryos for the first time, which raised ethical concerns about the
new frontier in science.
«Our future in medicine and in health depends on understanding the information contained in the
human genome, so it's a great topic for Science Week,» said Dr. Norma J. Nowak, Director of Science and Technology at UB's
New York State Center of Excellence in Bioinformatics and Life Sciences.
Allison Mackay, commenting on The Scientist's story about a
new, hand - held sequencer that can reportedly decode the entire
human genome.
From the Building with Biology website: «The Building with Biology project team has received supplemental funding from the National Science Foundation to develop a
new public forum on
human genome editing called Editing our Evolution: Rewriting the Humane Genome.&
genome editing called Editing our Evolution: Rewriting the Humane
Genome.&
Genome.»
«Our study shows that epigenetic drift, which is characterized by gains and losses in DNA methylation in the
genome over time, occurs more rapidly in mice than in monkeys and more rapidly in monkeys than in
humans,» explains Jean - Pierre Issa, MD, Director of the Fels Institute for Cancer Research at LKSOM, and senior investigator on the
new study.
An international team led by researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) has developed a
new technique for identifying gene enhancers — sequences of DNA that act to amplify the expression of a specific gene — in the
genomes of
humans and other mammals.
Diane Dickel is the lead author of Nature Methods paper describing a
new technique for identifying gene enhancers in the
genomes of
humans and other mammals.
On average, every duplication of the
human genome includes 100
new errors, so all that reproducing gave our DNA many opportunities to accumulate mutations.
«Our work demonstrates that the generation of
genome sequences from a large number of archaic
human individuals is now technically feasible, and opens the possibility to study Neandertal populations across their temporal and geographical range,» says Janet Kelso, the senior author of the
new study.
We want to understand the basic mechanism underlying these multiple
new copy number variant mutations in the
human genome.»
And with the recent unveiling of the
human genome sequence — to say nothing of the
new drugs that are being tested every day — those working in the patent field are busier than ever.
Now Pääbo and his colleagues have devised a
new method of genetic analysis that allowed them to reconstruct the entire Denisovan
genome with nearly all of the
genome sequenced approximately 30 times over akin to what we can do for modern
humans.
New methods for the removal of contaminating DNA from microbes and present - day
humans that were developed by the Leipzig group have now enabled the researchers to sequence the
genomes of five Neandertals from Belgium, France, Croatia, and Russia that are between 39,000 and 47,000 years old.
Since the completion of the
Human Genome Project in 2003, scientists have expanded their knowledge of how living cells work with
new approaches including genomics, proteomics, and systems biology.
At a recent Biology of
Genomes meeting, a biologist showed off a
new method to extensively survey
human cells for mysterious, sometimes gene - filled loops known as extrachromosomal circular DNA (eccDNA).
«We explored the opportunity of using sperm RNA elements as a predictor of
human health, with applications at the fertility clinic that would go hand - in - hand with the new neonatal intensive care unit genome sequencing to better health outcomes,» said Dr. Krawetz, associate director of the C.S. Mott Center for Human Growth and Develop
human health, with applications at the fertility clinic that would go hand - in - hand with the
new neonatal intensive care unit
genome sequencing to better health outcomes,» said Dr. Krawetz, associate director of the C.S. Mott Center for
Human Growth and Develop
Human Growth and Development.
«We'd like to develop the resources so that people can quickly test hypotheses about the
human genome by synthesising
new versions.»
In - depth analysis of the
human body's microflora has been possible only in the past few years — a by - product of the same
new gene sequencing techniques that have allowed scientists to cheaply and accurately identify the DNA of the
human genome.
Scientists poring over the 3 - billion - letter - long
genomes of
humans and mice made a host of
new discoveries in 2005.
This avenue of research is still
new, since we have only recently begun to decode the mysteries of the
human genome, but studies are emerging every year.
A series of fine - tuned maps of DNA packaging in
human cells reveal dynamic
new views of how the
genome's instructions are carried out to build a person.
Two years ago,
human genome researchers broke with tradition and agreed to release
new data on an ongoing basis (Science, 25 October 1996, p. 533).
«Gene variants modifying Huntington's symptom onset may lead to
new therapeutic strategies:
Genome - wide association analysis identifies sites associated with earlier - or later - than - expected symptom appearance in
human patients.»
The National
Human Genome Research Institute (NHGRI) in Bethesda, Maryland, forked over $ 25 million; the state of Texas, $ 10 million; the Canadian government, $ 5 million; and the governments of Australia and
New Zealand, $ 1 million each.
A
new high - coverage DNA sequencing method reconstructs the full
genome of Denisovans — relatives to both Neandertals and
humans — from genetic fragments in a single finger bone
Most drug companies seeking to apply the wealth of data on the
human genome to the hunt for
new drugs have turned to specialized start - up companies for help (Science, 7 February 1997, p. 767).
A
new study suggests that epigenetic effects — chemical modifications of the
human genome that alter gene activity without changing the DNA sequence — may sometimes influence sexual orientation.
The move comes in response to the announcement earlier this week of a
new U.S. company, launched by sequencing - machine manufacturer Perkin - Elmer and J. Craig Venter of The Institute for Genomic Research, that plans a brute - force approach to sequencing the
human genome within 3 years (ScienceNOW, 12 May).
«Sequencing the
human genome, device miniaturization, and the advent of combination devices have shifted the focus from engineering to the life sciences in the device industry,» adds Jules Mitchel, president of Target Health Inc. in
New York City, a company that conducts clinical trials for MD&D companies.
The rationale for sequencing and exploring the
human genome — to revolutionize the finding of
new drugs, diagnostics and vaccines, and to tailor treatments to the genetic make - up of individuals — is the same today.
Four countries — the United States, Canada,
New Zealand, and Australia — have already contributed a total of $ 53 million to sequence the cow
genome, which, like its
human counterpart, contains roughly 3 billion base pairs.
In 1975, the notion of using recombinant DNA to design
human babies was too remote to seriously consider, but the explosion of powerful
new genome - editing technologies such as CRISPR - Cas9, zinc fingers, and TALENs has changed that.
Intriguingly, the
new genetic resistance locus lies within a region of the
genome where
humans and chimpanzees have been known to share particular combinations of DNA variants, known as haplotypes.
They found that the Neanderthal
genome shows more similarity with non-African modern
humans throughout Europe and Asia than with African modern
humans, suggesting that the gene flow between us and Neanderthals most likely occurred outside Africa as
humans were en route to Europe, Asia, and
New Guinea.
To reach this conclusion, Pääbo and his team spent years sequencing the complete
genome of three Neanderthal bones from the Vindija Cave in Croatia and compared the results with the
genomes of five modern
humans from southern Africa, West Africa, Papua
New Guinea, China, and Western Europe.
The advance might drop the cost of sequencing a complete
human genome below $ 1000, which is expected to revolutionize personalized medicine and help usher in a
new era of genetic - based diagnostics and medicines.
He founded a
new company, Celera, and gambled on a «whole -
genome shotgun assembly» approach, in which the 3 billion «letters» of
human DNA would be fragmented, identified, and then put together in the correct order by computer.
Using these data, researchers identified four
new markers of primary sclerosing cholangitis risk on the
human genome, bringing the total number of known predisposing locations to 20.
«This study gives deep
new insights into the life of a parasitic fluke in the
human bile duct, and was enabled by the development of an exciting
new genome assembly tool called OPERA - LG in our lab.
He pointed out that the
new capabilities to precisely edit the
genome has sparked off an intense debate in the USA and elsewhere, since the
new precision tools could also be applied to modifying the
genome in
human germ cells or embryos.
Studies comparing the mouse and
human sequences that accompany the mouse
genome in the journal Nature suggest it provides plenty of
new leads in biology and disease.
Careful attention to phenotyping diseases, facilitated by our knowledge of the
human genome and computational analysis, has allowed observant physicians and physician - scientists to identify and categorize diseases in a manner that has informed basic science, given it
new contexts, and in many instances provided important
new directions for investigation.